Nav: Home

TSRI researchers identify gene responsible for mesenchymal stem cells' stem-ness'

January 22, 2018

JUPITER, FL - Jan. 22, 2018 - Many doctors, researchers and patients are eager to take advantage of the promise of stem cell therapies to heal damaged tissues and replace dysfunctional cells. Hundreds of ongoing clinical trials are currently delivering these therapies to patients worldwide.

Mesenchymal stem cells (MSCs) are popular tools for these therapies because they can differentiate into a variety of mature cell types such as bone, fat and cartilage. They also support hematopoiesis--the formation of blood cells--and secrete beneficial factors that promote tissue repair. Unfortunately, scientists often struggle to predict how these cells will act in different environments in the body.

Researchers on the Florida campus of The Scripps Research Institute (TSRI) recently published a study in the journal Cell Death and Differentiation identifying factors crucial to MSC differentiation, providing insight into how these cells should be studied for clinical purposes.

Primary MSCs from bone marrow are delicate, and it´s difficult to keep them alive in a petri dish. For this reason, most scientists studying them use cell lines, cells that have been altered to live and replicate indefinitely. To create immortal MSC lines, scientists delete a gene called p53 required for the cells to undergo normal, programmed cell death, called apoptosis. The new study, conducted by researchers in the lab of TSRI Professor Donald Phinney, PhD, shows that the gene influences far more than just apoptosis; it is also a master regulator of the cells' ability to differentiate.

"Many publications have used immortalized cells as MSC surrogates, but they may not mean much if they don't have functionally accurate p53," says Siddaraju Boregowda, PhD, a TSRI research associate and one of the study's two lead authors.

The researchers compared cells cultured from mice that did not express the p53 gene with cells that came from normal mice. They found that the level of active p53 was the master regulatory factor in determining how MSCs grow and differentiate. The study explains that the gene exerts its effects through its interactions with reactive oxygen species as well as two transcription factors: TWIST2 and PPARG.

When the researchers deleted p53 completely, the cells became immortal but quickly developed into bone. They lost their ability to promote hematopoiesis or become other types of cells, like fat. A low level of p53 induced TWIST2, which kept the MSCs in a stem state, rather than promoting any differentiation. A slightly higher level of p53 induced PPARG and reactive oxygen species, which led the cells to differentiate into fat cells, but not bone. At even higher levels of p53, the cells died.

A basal level of p53 in cells in the culture is required for them to act as an accurate model for cells in the body, explains Veena Krishnappa, PhD, the study's other lead author, previously a postdoctoral researcher in Phinney's lab.

In addition to suggesting that the dramatic effects of deleting p53 may make MSC cell lines an inappropriate surrogate to predict the cells' behavior in clinical applications, the study also suggests that inactivation of p53 may play multiple roles in the progression of bone cancers.

"P53 inactivation not only promotes sustained growth but also makes the cells insensitive to oxidative stress and short-circuits pathways that constrain cellular differentiation. Each of these changes likely contribute significantly to tumorigenesis and tumor progression," says Phinney. "Continuing to delineate the important role of MSCs in skeletal disease may open the door to devising new therapeutic interventions."
-end-
In addition to Boregowda, Krishnappa and Phinney, authors of the study, "Basal p53 expression is indispensable for mesenchymal stem cell integrity," include Jacqueline Strivelli, Christopher L. Haga and Cori N. Booker of The Scripps Research Institute.

This work was supported by funding from the National Institutes of Health (grant R24 OD18254).

Cover photo courtesy National Institutes of Health, Chun Yang, Hao Ma and Anouk Killaars, University of Colorado Boulder

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists--including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine--work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see http://www.scripps.edu.

Scripps Research Institute

Related Fat Articles:

Celebrity fat shaming has ripple effects on women's implicit anti-fat attitudes
Comparing 20 instances of celebrity fat-shaming with women's implicit attitudes about weight before and after the event, psychologists from McGill University found that instances of celebrity fat-shaming were associated with an increase in women's implicit negative weight-related attitudes.
The dangers of hidden fat: Exercise is your best defense against deep abdominal fat
Researchers analyzed two types of interventions -- lifestyle modification (exercise) and pharmacological (medicine) -- to learn how best to defeat fat lying deep in the belly.
Dietary fat is good? Dietary fat is bad? Coming to consensus
Which is better, a low-fat/high-carbohydrate diet or a high-fat/low-carbohydrate diet -- or is it the type of fat that matters?
New study on obesity: We inherit the dangerous fat from Dad -- and the good fat from Mom
Brown fat cells burn off a lot of calories, whereas an excess of white fat cells make us overweight and ill.
Innovative technique converts white fat to brown fat
Increasing healthy brown fat might help weight management and reduce symptoms of diabetes.
Fat cells control fat cell growth
Researchers from ETH Zurich and EPFL have discovered a new type of fat cell that suppresses the growth of new fat cells.
Dietary fat, changes in fat metabolism may promote prostate cancer metastasis
Researchers at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) shed new light on the genetic mechanisms that promote metastasis in the mouse model and also implicated the typical Western high-fat diet as a key environmental factor driving metastasis.
Scarring molecule in fat tissue links obesity with distressed fat
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.
Making fat mice lean: Novel immune cells control neurons responsible for fat breakdown
The biological causes underlying obesity have been under intense scrutiny with studies suggesting a link between the nervous and the immune systems.
Scientists find way to convert bad body fat into good fat
Working in mice, researchers at Washington University School of Medicine in St.
More Fat News and Fat Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab